跳至主要内容
临床试验/NL-OMON48768
NL-OMON48768已完成不适用

Role of bacterioPhages In gut Microbiome composition and glucose metabolism in Metabolic Syndrome subjects - PIMMS

Academisch Medisch Centrum0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Participants:
  • Caucasian male/female
  • Age: >=18 years old
  • BMI: >=25 kg/m2
  • At least 3 of the following criteria:
  • o Fasting plasma glucose >=5.6 mmol/L OR HOMA-IR index >=2.5
  • o Waist-circumference >=102 cm
  • o HDL cholesterol <=1.02 mmol/L
  • o Blood pressure >=130/85 mmHg
  • o Triglycerides >=1.7 mmol/L
  • Subjects should be able to give informed consent
  • Caucasian male/female
  • Age: >18 years old
  • BMI: 18-25 kg/m2
  • Subjects should be able to give informed consent

排除标准

  • Participants:
  • A history of cardiovascular event (cerebrovascular accident (CVA), myocardial
  • infarction (MI)) or pacemaker implantation
  • Use of any medication including proton pump inhibitors, antibiotics and
  • pro-/prebiotics in the past three months or during the study period
  • (Expected) prolonged compromised immunity (due to recent cytotoxic
  • chemotherapy or human immunodeficiency viruses (HIV) infection with a CD4 count
  • < 240/mm3)
  • Presence of overt type 1 diabetes mellitus (T1DM) or T2D
  • History of chronic diarrhoea (>=3 stools/day for >4 weeks), chronic
  • obstipation (<2 defecations/week for >3 months), Irritable Bowel Syndrome (IBS)
  • (according to Rome IV criteria) or Inflammatory Bowel Disease (IBD).
  • Smoking or illicit drug use (MDMA/amphetamine/cocaine/heroin/GHB) in the past
  • three months or use during the study period
  • Use of >5 units of alcohol daily on average in the past three months or use
  • of >2 units of alcohol during the study period
  • History of cholecystectomy
  • Use of any medication including proton pump inhibitors, antibiotics and
  • pro-/prebiotics in the past three months or during the study period
  • History of, or known exposure to HIV, hepatitis B (HBV) or C virus (HCV),
  • syphilis, human T-lymphotropic virus (HTLV) I and II, malaria, trypanosomiasis,
  • tuberculosis
  • Known systemic infection not controlled at the time of donation
  • Smoking or illicit drug use (MDMA/amphetamine/cocaine/heroin/GHB) in the past
  • three months or use during the study period
  • Use of >5 units of alcohol daily on average in the past three months or use
  • of >2 units of alcohol during the study period
  • Risky sexual behaviour (anonymous sexual contacts; sexual contacts with
  • prostitutes, drug addicts, individuals with HIV, viral hepatitis, syphilis;
  • work as prostitute; history of sexually transmittable disease)
  • Previous reception of tissue/organ transplant
  • Previous (<12 months) reception of blood products
  • Recent (<6 months) needle stick accident
  • Recent (<6 months) body tattoo, piercing, earring, acupuncture
  • Recent medical treatment in poorly hygienic conditions
  • Risk of transmission of diseases caused by prions
  • Recent parasitosis or infection from rotavirus, Giardia lamblia and other
  • microbes with GI involvement
  • Recent (<6 months) travel in tropical countries, countries at high risk of
  • communicable diseases or traveller's diarrhoea
  • Recent (<6 months) history of vaccination with a live attenuated virus, if
  • there is a possible risk of transmission
  • Healthcare providers having frequent patient contact (to exclude the risk of
  • transmission of multidrug-resistant organisms)
  • Individual working with animals (to exclude the risk of transmission of
  • zoonotic infections)
  • History of IBS (according to Rome IV criteria), IBD, functional chronic
  • constipation, coeliac disease, other chronic GI disorders
  • History of chronic, systemic autoimmune disorders with GI involvement
  • History of, or high risk for, GI cancer or polyposis
  • 另有 6 项未显示

研究者

相似试验